Moomoo AIのまとめ
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, indicating that they no longer beneficially own more than five percent of bluebird bio, Inc.'s common stock. The filing, dated September 30, 2024, shows that each reporting person now owns 0% of the company's common stock, effectively ceasing their status as major shareholders. The addresses for all reporting persons are listed as 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, with Alyeska Investment Group and Alyeska Fund GP, LLC classified as investment advisers and parent holding companies or control persons. The certification signed by Jason Bragg, Chief Financial Officer for both Alyeska entities, and Anand Parekh individually, asserts that the shares were acquired and held in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio, Inc.
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, indicating that they no longer beneficially own more than five percent of bluebird bio, Inc.'s common stock. The filing, dated September 30, 2024, shows that each reporting person now owns 0% of the company's common stock, effectively ceasing their status as major shareholders. The addresses for all reporting persons are listed as 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. The filing was made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, with Alyeska Investment Group and Alyeska Fund GP, LLC classified as investment advisers and parent holding companies or control persons. The certification signed by Jason Bragg, Chief Financial Officer for both Alyeska entities, and Anand Parekh individually, asserts that the shares were acquired and held in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio, Inc.
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC、Anand Parekhは、アメリカ合衆国証券取引委員会に修正されたSchedule 13G/Aを提出し、bluebird bio, Inc.の普通株式の5％以上を益する形で保有していないことを示しています。この提出は2024年9月30日付けで、各報告者が同社の普通株式の0％を現在保有していることを示しており、実質的に主要株主としての地位を終了しています。すべての報告者の住所は、77 West Wacker Drive, 7th Floor, Chicago, IL 60601と記載されてい...すべて展開
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC、Anand Parekhは、アメリカ合衆国証券取引委員会に修正されたSchedule 13G/Aを提出し、bluebird bio, Inc.の普通株式の5％以上を益する形で保有していないことを示しています。この提出は2024年9月30日付けで、各報告者が同社の普通株式の0％を現在保有していることを示しており、実質的に主要株主としての地位を終了しています。すべての報告者の住所は、77 West Wacker Drive, 7th Floor, Chicago, IL 60601と記載されています。この提出は、1934年の証券取引法のRule 13d-1(b)に基づいて行われ、Alyeska Investment GroupとAlyeska Fund GP, LLCは投資顧問および親持株会社または支配者として分類されています。両Alyeskaの企業の最高財務責任者であるJason BraggとAnand Parekhが個別に署名した証明書は、株式がビジネスの通常の範囲内で取得され保有されたものであり、bluebird bio, Inc.の支配権を変更または影響を与える目的ではないと主張しています。
役に立った
役に立たない
